Skip to main content

Table 3 Lab results

From: Effect of insulin resistance on CAC scores in cancer survivors

 

Insulin Sensitive (N = 32)

IR - Prediabetic (N = 29)

IR - Diabetic (N = 29)

Total (N = 90)

P-value

Cholesterol

    

0.117

Mean (SD)

196.3 (42.8)

186.0 (45.5)

172.4 (45.4)

185.3 (45.1)

 

Range

99.0–299.0

91.0–281.0

88.0–277.0

88.0–299.0

 

HDL

    

< 0.001

Mean (SD)

69.5 (19.6)

54.6 (13.3)

51.1 (13.9)

58.8 (17.8)

 

Range

42.0–115.0

27.0–76.0

31.0–81.0

27.0–115.0

 

LDL

    

0.287

Mean (SD)

107.1 (37.4)

105.5 (41.2)

92.5 (37.7)

101.9 (38.9)

 

Range

41.0–195.0

30.0–191.0

6.0–163.0

6.0–195.0

 

Exogenous Insulin

0 (0.0%)

0 (0.0%)

17 (58.6%)

17 (18.9%)

< 0.001

Fasting Insulin

    

0.003

Mean (SD)

8.8 (4.3)

22.4 (31.3)

39.3 (49.7)

23.0 (35.4)

 

Range

2.6–21.6

2.6–168.0

3.0–172.0

2.6–172.0

 

Fasting Glucose

    

< 0.001

Mean (SD)

94.4 (7.3)

112.1 (16.3)

139.2 (61.3)

114.5 (40.4)

 

Range

79.0–106.0

73.0–141.0

6.9–291.0

6.9–291.0

 

HOMA-IR

    

0.006

Mean (SD)

2.1 (1.1)

6.7 (10.9)

9.1 (10.2)

5.8 (8.9)

 

Range

0.6–5.0

0.8–58.5

0.8–48.1

0.6–58.5

 

HgbA1c

    

< 0.001

Mean (SD)

5.2 (0.2)

5.7 (0.4)

7.5 (1.9)

6.1 (1.5)

 

Range

4.4–5.6

4.8–6.2

5.2–12.6

4.4–12.6

 

oGTT

     

N

32

11

0

43

 

Mean (SD)

94.7 (28.0)

162.7 (25.1)

-

112.1 (40.4)

 

Range

47.0–138.0

125.0–199.0

-

47.0–199.0

 
  1. P-values come from ANOVA for continuous measures, and Fisher’s Exact Test for categorical measures